Breaking News

Crucial FDA drug reviews expected to be slowed by job cuts

April 10, 2025
Adobe

STAT+ | Crucial FDA drug reviews expected to be slowed by job cuts

A former top FDA official said it's only a matter of time before the chaos at the agency starts to impact drug reviews. 

By Lizzy Lawrence, Matthew Herper, and Elaine Chen


RFK Jr. suggests some vaccines are risky or ineffective, downplays measles threat

The comments, dismissed by health experts, come as the HHS secretary faces a growing outbreak of measles that could test his leadership.

By Daniel Payne


Government shuts CDC office focused on alcohol-related harms and prevention

At least 11 states relied on the 24-year-old program for funding, data assistance and guidance. Three-person office oversaw a budget of about $6 million.

By Isabella Cueto



Molly Ferguson/STAT

STAT+ | The trade war hits pause, but the biotech doom loop carries on

In this week's edition of "Adam's Biotech Scorecard," fund managers and others tell Adam they still see plenty of reason to worry.

By Adam Feuerstein


STAT+ | House conservatives cave on a key demand, decreasing threat of Medicaid cuts

The budget blueprint, which passed largely on party lines, sets the stage for a bill later in the year on Trump's major tax cut plan.

By John Wilkerson


STAT+ | Gilead is urged to rework licensing deals for groundbreaking HIV prevention drug

A group of academics argue voluntary licensing deals pursued by Gilead on lenacapavir are too restrictive, which will delay or deny access to the drug.

By Ed Silverman


Adobe

Opinion: The wellness industry is killing animals, spreading disease, and fueling the next pandemic

Wellness misinformation isn't just rampant in human health — it's deeply embedded in veterinary health, too.

By Andrea Love


STAT+ | Mayo Clinic taps former Biden administration official to oversee its use of AI

Micky Tripathi, former top HHS official, to join Mayo Clinic as a senior executive overseeing implementation of AI across the health system.

By Casey Ross


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments